复发宫颈癌不同治疗方式对预后的相关影响

目的：对复发宫颈癌不同治疗方式对预后的相关影响进行分析和探讨。方法方便收集该院2013年3月—2016年3月期间的复发宫颈癌患者110例,其中有24例患者进行了盆腔清扫手术,有65例患者进行了放疗与化疗相结合,有13例患者进行了单纯化疗,有8例患者进行了单纯的放疗。然后对各组患者的复发距初治的时间以及存活率进行比较和分析。结果该次研究110例患者,存活期最短是1个月,最长9年。各组比较,1年内复发存活率最低45.83%,最高62.50%,平均复发存活率51.55%；2年内复发存活率最低25.0%,最高为36.92%,平均复发存活率35.05%；2年以上复发存活率最低10.77%,最高20.83%,平均存活率为13.40%,差异无统计学意义(P>0.05)。结论对于宫颈癌患者来说,在手术之后要及时进行诊断检查,目前临床医学对于复发宫颈癌缺乏有效的治疗方式,所以该文提倡根据患者的实际病情,采取个性化的治疗方式对宫颈癌患者进行治疗。

Effect of Different Treatment Modalities on the Prognosis of Recurrent Cer-vical Cancer

Objective To analyze and discuss the influence of different treatment for recurrent cervical cancer prognosis. Methods Convenient selection 110 patients with recurrent cervical cancer in our hospital from March 2013 to March 2016 months during the period of the cases, including 24 cases of pelvic dissection, 65 cases who underwent radiotherapy and chemotherapy. Together, there were 13 patients who underwent chemotherapy, 8 cases underwent simple radiotherapy. Then we assessedrecurrence from initial treatment time and survival rate were compared and analyzed. Results In this study 110 patients, survival is one of the shortest month, up to 9 years. Each group, one year recurrence-free survival minimum 45.83 percent, up 62.50%, 51.55%average recurrence-free survival; minimum 2 years recurrence-free survival was 25.0%, up to 36.92%, 35.05% average recurrence-free survival; more than 2 years of recurrence-free survival the lowest rate of 10.77 percent, up 20.83 percent, with an average survival rate was 13.40%. The difference was no statistically significant (P>0.05). Conclusion For patients with cervical cancer. Said after the surgery to be timely diagnosis, at present clinical medicine lack of effective treatment for recurrent cervical cancer, so this paper advocates according to the actual condition of the patients, to take an individualized treatment approach for the treatment of patients with cervical cancer.